Illumina, Inc. - ILMN - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Illumina, Inc. - SIC # 3826

Ticker	Exchange	SIC #	Website	Latest Ticker
ILMN	Nasdaq	3826	http://www.illumina.com/	72.58 -0.50
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Illumina, Inc. Opportunities in Hepatitis C and Genomic Technologies: a Wall Street Transcript Interview with David Ferreiro, Executive Director and Senior Analyst at Oppenheimer & Co. Inc. - May 21st, 2013 12:23 pm Splicing & Dicing Myriad Genetics Amidst the Angelina Jolie Disclosure - May 21st, 2013 11:52 am QIAGEN Downgraded to Strong Sell - May 21st, 2013 11:50 am The 3 Deadliest Diseases in the U.S. - May 20th, 2013 12:00 pm Illumina Inc. Presents at UBS Global Healthcare Conference, May-20-2013 11:30 AM - May 20th, 2013 11:50 am UK tries out new model for gene testing in cancer patients - May 20th, 2013 8:14 am UK tries out new model for gene testing in cancer patients - May 20th, 2013 8:14 am U.K. to Pilot Illumina Genetic Test for Breast, Ovarian Cancer - May 20th, 2013 7:50 am IBD 50: Top 5 Medical Stocks Include Celgene, Actavis - May 18th, 2013 6:05 am How one bull is sticking with Illumina - May 17th, 2013 9:28 am A Portfolio Construction Strategy with an Emphasis on High-Innovation, Breakthrough Biotech and Pharmaceutical Companies - May 16th, 2013 1:39 pm Gene-Testing Dispute Focuses on How Much a Patient Should Know - May 16th, 2013 12:00 pm Illumina Launches BaseSpace® Apps - May 16th, 2013 4:30 am Much Awaited Test Launch by Genomic - May 15th, 2013 12:30 pm Myriad Soars Higher on Celeb Clout - May 15th, 2013 12:00 pm Tyco Electronics CEO Sells More Than 59K Shares and 4 Insider Sales to Note - May 15th, 2013 7:19 am Illumina to partner for automation of sample preparation kits - May 15th, 2013 4:36 am Illumina Announces Partnerships to Automate TruSeq® and Nextera® Sample Preparation Kits - May 15th, 2013 4:30 am The Hidden Opportunity of the Novel Coronavirus - May 15th, 2013 3:53 am Illumina Inc. (ILMN): Today's Featured Drugs Laggard - May 13th, 2013 3:01 pm View All Current Headlines >>